{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:51:38Z","timestamp":1774576298008,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ijid.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T18:40:27Z","timestamp":1660761627000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study"],"prefix":"10.1016","volume":"123","author":[{"given":"Matilde","family":"S\u00e1nchez-Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Vizcarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Gion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Martialay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Taboada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-8871","authenticated-orcid":false,"given":"Alberto","family":"Alonso-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Sampayo-Cordero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Malfettone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Tena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio De La","family":"Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Llombart-Cussac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.08.007_bib0001","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2022.08.007_bib0002","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2022.08.007_bib0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2021.12.327","article-title":"Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry","volume":"116","author":"Calder\u00f3n-Parra","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.08.007_bib0004","series-title":"StatPearls","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2021"},{"key":"10.1016\/j.ijid.2022.08.007_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2020.05.026","article-title":"Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019","volume":"135","author":"Di Cosimo","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijid.2022.08.007_bib0006","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0008","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0009","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0010","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2020.6820","article-title":"CORIMUNO-19 Collaborative Group. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial","volume":"181","author":"Hermine","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0012","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22310","article-title":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2022.08.007_bib0014","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jcph.1693","article-title":"A comprehensive review of tocilizumab in COVID-19 acute respiratory distress syndrome","volume":"60","author":"Khiali","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0015","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0016","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4269\/ajtmh.20-1110","article-title":"Factors of severity in patients with COVID-19: cytokine\/chemokine concentrations, viral load, and antibody responses","volume":"103","author":"Kwon","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.08.007_bib0017","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1158\/0008-5472.CAN-17-0740","article-title":"IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer","volume":"77","author":"Lamichhane","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijid.2022.08.007_bib0018","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102512","article-title":"Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab","volume":"114","author":"Morrison","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijid.2022.08.007_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/07357907.2020.1844893","article-title":"Course of Sars-CoV2 infection in patients with cancer treated with anti-PD-1: a case presentation and review of the literature","volume":"39","author":"Pala","year":"2021","journal-title":"Cancer Investig"},{"key":"10.1016\/j.ijid.2022.08.007_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","article-title":"PD-1-Expressing SARS-CoV-2-Specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19","volume":"54","author":"Rha","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2022.08.007_bib0022","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8+ T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0023","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe COVID-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0024","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2022.08.007_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.695242","article-title":"PD-L1 dysregulation in COVID-19 patients","volume":"12","author":"Sabbatino","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 Is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142167","article-title":"High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19","volume":"5","author":"Schub","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijid.2022.08.007_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12871-017-0304-8","article-title":"Feasibility of the modified sequential organ function assessment score in a resource-constrained setting: a prospective observational study","volume":"17","author":"Sendagire","year":"2017","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0029","first-page":"569","article-title":"Experience in the management of severe COVID-19 patients in an intensive care unit","volume":"88","author":"Sosa-Garc\u00eda","year":"2020","journal-title":"Cir Cir"},{"key":"10.1016\/j.ijid.2022.08.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173644","article-title":"Treatment for COVID-19: an overview","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0031","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2022.08.007_bib0032","series-title":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020","year":"2020"},{"key":"10.1016\/j.ijid.2022.08.007_bib0033","series-title":"Clinical management of severe acute respiratory infection when novel coronavirus (NCoV) infection is suspected. Interim guidance","year":"2020"},{"key":"10.1016\/j.ijid.2022.08.007_bib0034","series-title":"WHO coronavirus (COVID-19) dashboard","year":"2021"},{"key":"10.1016\/j.ijid.2022.08.007_bib0035","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2022.08.007_bib0036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijid.2022.08.007_bib0037","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1097\/CCM.0000000000004411","article-title":"Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019","volume":"48","author":"Zou","year":"2020","journal-title":"Crit Care Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:08:30Z","timestamp":1761120510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222004751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":37,"alternative-id":["S1201971222004751"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.08.007","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1386212\/v1","asserted-by":"object"}]},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}